| 000 | 00987 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513131430.0 | ||
| 264 | 0 | _c19971210 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.315.7116.1160b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaty, D W | |
| 245 | 0 | 0 |
_aFunding of drug treatment of multiple sclerosis should not be delayed. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cNov 1997 |
||
| 300 |
_a1160-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xeconomics |
| 650 | 0 | 4 | _aCapital Financing |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-beta _xeconomics |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 315 _gno. 7116 _gp. 1160-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.315.7116.1160b _zAvailable from publisher's website |
| 999 |
_c9344768 _d9344768 |
||